Editorial |
From the Department of Pathology, University of Chicago, Chicago, Ill.
Correspondence to Dr Godfrey S. Getz, Department of Pathology, University of Chicago, 5841 S Mayfield Ave, BH-329, MC 3083, Chicago, IL 60637-1470. E-mail g-getz@uchicago.edu
Key Words: Editorials apolipoprotein E mouse innominate artery atherosclerosis plaque complications
The
study reported in this issue of
Arteriosclerosis, Thrombosis, and Vascular
Biology by Rosenfeld et
al1 is very important
in experimental atherosclerosis for 2 reasons. First,
the study shows that there is an available murine model that expresses
many features of the human plaque that are very relevant to the
pathogenesis of clinically significant disease. Second, the study shows
that there is a site of the arterial tree other than the
aortic root that (in the appropriate models) almost invariably develops
a lesion that begins with the accumulation of foam cells and progresses
to the advanced lesion of the sort shown in the study. Many recent
studies of atherosclerosis report on results
exclusively based on the aortic root, not a frequent site of clinically
significant lesions in humans. The innominate artery is an alternate
site for the study of the pathogenesis of
atherosclerosis. There has been shown to be a high
frequency of extensive lesions at this site in apolipoprotein E
(apoE)null mice by 24 to 28 weeks of age, even if these mice are
maintained on a chow diet (Reardon et al, unpublished observations,
2000), and this could be shortened if the mice are fed a Western-type
diet. This makes it a site worthy of study even for shorter-term
experiments. Although the aortic root may be easy to study, its lesion
responses are not invariably reflective of the situation elsewhere in
the vascular tree. We note that the aortic root and the innominate
artery respond differently to immune deficiency
This article has been cited by other articles:
![]() |
F. Bea, J. Kreuzer, M. Preusch, S. Schaab, B. Isermann, M. E. Rosenfeld, H. Katus, and E. Blessing Melagatran Reduces Advanced Atherosclerotic Lesion Size and May Promote Plaque Stability in Apolipoprotein E- Deficient Mice Arterioscler Thromb Vasc Biol, December 1, 2006; 26(12): 2787 - 2792. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. VanderLaan, C. A. Reardon, and G. S. Getz Site Specificity of Atherosclerosis: Site-Selective Responses to Atherosclerotic Modulators Arterioscler Thromb Vasc Biol, January 1, 2004; 24(1): 12 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cullen, R. Baetta, S. Bellosta, F. Bernini, G. Chinetti, A. Cignarella, A. von Eckardstein, A. Exley, M. Goddard, M. Hofker, et al. Rupture of the Atherosclerotic Plaque: Does a Good Animal Model Exist? Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 535 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Hockings, T. Roberts, G. J. Galloway, D. G. Reid, D. A. Harris, M. Vidgeon-Hart, P. H.E. Groot, K. E. Suckling, and G. M. Benson Repeated Three-Dimensional Magnetic Resonance Imaging of Atherosclerosis Development in Innominate Arteries of Low-Density Lipoprotein Receptor-Knockout Mice Circulation, September 24, 2002; 106(13): 1716 - 1721. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Lentz Does Homocysteine Promote Atherosclerosis? Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1385 - 1386. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |